Position in EVO
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$464,926
+$159,061 QoQ
Shares Held
166,045
+35.7% QoQ
Ownership
0.047%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 34 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in EVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026LPL Financial LLC holds $154,257,402 across 47 Drug Manufacturers - Specialty & Generic names. EVO ranks #29 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
368,249 | $26,462,373 | |
| 2 | HLN |
Haleon plc
|
2,036,156 | $18,997,335 | |
| 3 | PRGO |
PERRIGO Co plc
|
1,431,267 | $14,870,864 | |
| 4 | VTRS |
Viatris Inc
|
678,057 | $10,767,545 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
432,525 | $10,644,440 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
62,420 | $10,520,266 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
258,667 | $8,967,984 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
555,228 | $8,900,304 |
All Filings in EVO
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $464,926 | 166,045 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $305,865 | 122,346 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $291,445 | 94,625 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $274,649 | 75,661 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $158,949 | 37,845 | Shares | Sole | 2025-08-12 | |
| No filing history on record for this holder in this stock. | ||||||